4′-Methoxyresveratrol Improves Hepatic Insulin Resistance Induced by a High-Fat-Diet via Anti-Oxidative-Stress Activity
Diabetes, Metabolic Syndrome and Obesity · 2025-08 · Volume 18 · 2739-2752
DOI: 10.2147/dmso.s535103 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, Metabolic Syndrome and Obesity, 2025-08. Verfasst von Zhimei Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Hebei General Hospital, Shijiazhuang, Hebei, 050000, People's Republic of China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Background
Obesity and a high-fat diet (HFD) are key factors contributing to hepatic fat accumulation and type 2 diabetes mellitus (T2DM). Research indicates that oxidative stress induced by HFD mediates hepatic insulin resistance (HIR) through mechanisms such as promoting inflammation and lipid accumulation. Given that 4'-methoxyresveratrol (4-MR) exhibits remarkable anti-inflammatory and antioxidant activities, it is of great research significance to explore whether it can effectively counteract HFD-induced HIR by enhancing antioxidant stress.
Purpose
This study aimed to explore the effects of 4MR on liver oxidative damage and insulin sensitivity.
Methods
Mice were fed a HFD for 8 weeks, followed by an intraperitoneal glucose tolerance test to assess insulin resistance. The in-vivo experiments were divided into three groups, including the control group, the HFD group, and the HFD + 4MR group. After 6 weeks of 4MR treatment, blood and liver samples were analyzed for biochemical markers, lipid peroxidation, antioxidant capacity, and liver protein levels. Insulin-resistant HepG2 cells were treated with 4MR and evaluated for proliferation and toxicity.
Results
4MR reduced fasting blood glucose and lipid levels, improved insulin sensitivity, and decreased liver malondialdehyde levels, while increasing catalase and antioxidant enzyme activities. In both mice and HepG2 cells, 4MR increased Sirt1, p-FOXO1, and CAT expression levels and decreased FOXO1 expression levels.
Conclusion
4MR alleviated hepatic oxidative stress, enhanced insulin sensitivity, and reduced glucose levels.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Endocrinology, Hebei General Hospital, Shijiazhuang, Hebei, 050000, People's Republic of China.
- Section of Rheumatology and Immunology, Hebei General Hospital, Shijiazhuang, Hebei, 050000, People's Republic of China.
- Physical Examination Center, Hebei General Hospital, Shijiazhuang, Hebei, 050000, People's Republic of China.
ORCID-Profile: Xuemei Zhang, Liqun Yang, Qian Nie
Zitieren
APA
Zhang, Z., Zhang, X., Yang, L., Nie, Q., & Song, G. (2025). 4′-Methoxyresveratrol Improves Hepatic Insulin Resistance Induced by a High-Fat-Diet via Anti-Oxidative-Stress Activity. Diabetes, Metabolic Syndrome and Obesity, Volume 18, 2739-2752. https://doi.org/10.2147/dmso.s535103
Vancouver
Zhang Z, Zhang X, Yang L, Nie Q, Song G. 4′-Methoxyresveratrol Improves Hepatic Insulin Resistance Induced by a High-Fat-Diet via Anti-Oxidative-Stress Activity. Diabetes, Metabolic Syndrome and Obesity. 2025;Volume 18:2739-2752. doi:10.2147/dmso.s535103
BibTeX
@article{Zhang2025,
author = {Zhang, Zhimei and Zhang, Xuemei and Yang, Liqun and Nie, Qian and Song, Guangyao},
title = {4′-Methoxyresveratrol Improves Hepatic Insulin Resistance Induced by a High-Fat-Diet via Anti-Oxidative-Stress Activity},
journal = {Diabetes, Metabolic Syndrome and Obesity},
year = {2025},
volume = {Volume 18},
pages = {2739--2752},
doi = {10.2147/dmso.s535103}
}
EUVIMED